Heartflow (HTFL) Surges 46%: Could This Be the Next Big Play in the Chip Supply Chain?
Heartflow Inc. (NASDAQ:HTFL), koronar arter hastalığı teşhisinde kullanılan AI tabanlı çözümleriyle dikkat çeken bir medikal teknoloji şirketi, geçen
Heartflow Inc. (NASDAQ:HTFL), a medical technology company specializing in AI-driven solutions for coronary artery disease, surged 46% last week, becoming one of the top gainers on the stock market. Its 48% revenue growth in Q2 validated its optimistic full-year outlook of 40-42% growth to $246-$250 million. CEO John Farquhar highlighted the durability of its FFR business model and the rapid growth potential of its Plaque division. Stifel analysts raised their price target to $45, citing the company's Q2 performance exceeding expectations. This development is being viewed as another sector play benefiting from the chip supply chain dynamics, particularly in the wake of Nvidia's chip crisis. How will markets react to this trend? Is this a new frontier in the semiconductor supply chain?
Related News & Analysis
View All →
Singh Joins Mayfield: A New Era for Chip Investments
Ramp Unveils Model Router, Steering the AI Landscape into a New Era
WNBA’s Landmark Pay Raise: 364% Surge in Player Wages Sparks Labor Milestone
Gen Z Rewrites the American Dream in the Great Postponement
Inertia Enterprises Cuts Fusion Fuel Loading to Hours, Shaking the Energy Market
Patreon Unveils 30 New Features to Revolutionize Creator Ecosystem
Latest Market News
All News →Rising Yields Threaten to Burst the Stock-Market Bubble: How Markets Will React
Human Capital Resilience in the Age of AI: Implications for Financial Markets
![[ALKLC] ALTINKILIÇ GIDA VE SÜT SANAYİ TİCARET A.Ş.
Katılım Finansı İlkeleri Bilgi Formu - Katılım Finansı İlkeleri Bilgi Formu](/_next/image?url=%2Fuploads%2Fkap-default.png&w=3840&q=75)
[ALKLC] ALTINKILIÇ GIDA VE SÜT SANAYİ TİCARET A.Ş. Katılım Finansı İlkeleri Bilgi Formu - Katılım Finansı İlkeleri Bilgi Formu
Turkey Cuts Inflation Target from 75–80% to 30%: Bolat’s Bold Move
Hyperliquid Goes to the US: Regulatory and Market Shockwaves